SOLID MALIGNANCIES
Clinical trials for SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is the first study testing a new cancer drug called SKB571 in people. Researchers want to find the safest dose and see if it shows any early signs of fighting advanced solid tumors. The study will enroll about 138 adults whose cancer has spread or cannot be removed by surger…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cancer drug enters first human trials for advanced cases
Disease control Recruiting nowThis is the first study in people to test a new cancer drug called IM-1021. The main goals are to find a safe dose and see how the body processes the drug in adults with advanced solid tumors or blood cancers that have not responded to standard treatments. Researchers will also l…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is the first study in people to test a new drug called CMAB017 for advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 55 patients with various advanced cancers will rece…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New cancer pill enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage study is testing a new oral drug called CT7439 in people with advanced solid cancers that have spread or cannot be cured. The main goal is to find out if the drug is safe and what side effects it causes, both when given alone and when combined with other cancer t…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC